All News

Researchers addressed the association between COVID-19 vaccination status and incidents of post-COVID condition.

Check out these important FDA updates from the month of May 2024.

Take a look back at the conference coverage you may have missed this month.

Roche's self-collection kit allows women to screen for cervical cancer at home, offering an alternative to a visit to a health care provider and promoting early detection of the disease.

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

The drug will be available in pharmacies during the second half of 2024.

Check out these featured Drug Topics expert interviews from May 2024.

Catch up on important continuous glucose monitoring (CGM) news from the month of May.

After 24 weeks of participation in an AI-driven lifestyle coaching program, 78% of all participants achieved a clinically meaningful SBP reduction of 5 mm Hg or greater.

Check out this list of our 10 most read stories from May 2024.

Eculizamab-aeeb is the 53rd FDA-approved biosimilar in the US.

While US health officials continue to monitor the outbreak in dairy cattle across the country, a second human recently tested positive after a mutation of the bird flu virus.

Emergency department visits tripled by December 2022 compared with the pre-legalization period from January 2015 to September 2018.

A recent study found that if community pharmacists were utilized to treat common conditions, it could result in significant cost-savings for the health care system.

Check out these top featured stories from Drug Topics in May 2024.

To assess the extent of FTC regulation, researchers collected data from the group’s merger and enforcement actions in a 22-year span.

In case you missed it, this week we had news about student-athlete suicides, the benefits of omega-3, the rise in tianeptine across the US, and more.

Check out important updates from the FDA for the week of May 20.

Experienced litigation lawyer Mark Cuker sat down with Drug Topics to discuss pharmacy benefit managers and their often corrupt practices.

Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.

In an abstract presented at Digestive Disease Week 2024, researchers analyzed Clostridioides difficile episodes and identified the risk factors and potential medications that caused them.

During a May 16 hearing titled “Rural Health Care: Supporting Lives and Improving Communities,” members discussed the need for better health care resources among rural communities in the US.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, discusses what tianeptine is and how pharmacists can help warn the public about its potential hazards.

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

Test your knowledge of asthma and allergy triggers.

Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.

A report from Dexcom found that depression and anxiety are commonly reported in patients living with type 2 diabetes, but continuous glucose monitors can make disease management easier.

Participants with the hungry gut phenotype, identified by the MyPhenome Hungry Gut test, were able to lose double the amount of weight on semaglutide compared to those without.